CH621552A5 - - Google Patents

Download PDF

Info

Publication number
CH621552A5
CH621552A5 CH1316374A CH1316374A CH621552A5 CH 621552 A5 CH621552 A5 CH 621552A5 CH 1316374 A CH1316374 A CH 1316374A CH 1316374 A CH1316374 A CH 1316374A CH 621552 A5 CH621552 A5 CH 621552A5
Authority
CH
Switzerland
Prior art keywords
dimethyl
pyrazole
amino
hydrogen
dihydrochloride
Prior art date
Application number
CH1316374A
Other languages
German (de)
English (en)
Inventor
Ronnie Ray Crenshaw
George Michael Luke
Paul Siminoff
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CH621552A5 publication Critical patent/CH621552A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
CH1316374A 1973-10-01 1974-09-30 CH621552A5 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/402,657 US4013665A (en) 1973-10-01 1973-10-01 Antiviral, substituted 1,3-dimethyl-1h-pyrazolo(3,4b)quinolines

Publications (1)

Publication Number Publication Date
CH621552A5 true CH621552A5 (sk) 1981-02-13

Family

ID=23592812

Family Applications (3)

Application Number Title Priority Date Filing Date
CH1316374A CH621552A5 (sk) 1973-10-01 1974-09-30
CH1180A CH619712A5 (sk) 1973-10-01 1980-01-03
CH484580A CH622793A5 (sk) 1973-10-01 1980-06-24

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH1180A CH619712A5 (sk) 1973-10-01 1980-01-03
CH484580A CH622793A5 (sk) 1973-10-01 1980-06-24

Country Status (19)

Country Link
US (1) US4013665A (sk)
JP (1) JPS582948B2 (sk)
BE (1) BE820400A (sk)
CA (1) CA1032538A (sk)
CH (3) CH621552A5 (sk)
CY (1) CY1087A (sk)
DE (1) DE2446821A1 (sk)
DK (1) DK516274A (sk)
ES (1) ES430554A1 (sk)
FI (1) FI57414C (sk)
FR (1) FR2245369B1 (sk)
GB (1) GB1488692A (sk)
HK (1) HK59380A (sk)
KE (1) KE3086A (sk)
MY (1) MY8100219A (sk)
NL (1) NL7412959A (sk)
NO (1) NO143223C (sk)
SE (1) SE419760B (sk)
ZA (1) ZA746138B (sk)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848968B (en) * 1983-11-18 1986-06-25 Riker Laboratories Inc 1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
WO1992018488A1 (fr) * 1991-04-10 1992-10-29 Japan Tobacco Inc. Nouveau derive d'oxazinone
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5506236A (en) * 1994-04-28 1996-04-09 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US6008226A (en) * 1995-03-10 1999-12-28 Sanofi-Synthelabo Substituted N-arylmethyl and heterocylylmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
US5614530A (en) * 1995-03-10 1997-03-25 Sterling Winthrop Inc. Substituted N-arylmethyl and heterocyclmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
US5488055A (en) * 1995-03-10 1996-01-30 Sanofi Winthrop Inc. Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof
WO2003045920A1 (en) * 2001-11-27 2003-06-05 Merck & Co., Inc. 4-aminoquinoline compounds
CA2468015A1 (en) * 2001-11-27 2003-06-05 Merck & Co., Inc. 2-aminoquinoline compounds
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
US8889154B2 (en) 2005-09-15 2014-11-18 Medicis Pharmaceutical Corporation Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
EP1889609B1 (en) * 2006-07-18 2019-05-22 Meda AB Immune response modifier foam formulations
AU2007279376B2 (en) * 2006-07-31 2012-09-06 Wirra Ip Pty Ltd Immune response modifier compositions and methods
CA2741303A1 (en) * 2008-10-28 2010-06-03 Schering Corporation Substituted pyrazoloquinolines and derivatives thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1152421B (de) * 1961-03-21 1963-08-08 Bayer Ag Verfahren zur Herstellung von 4-Hydroxy-pyrazolo[3, 4-b]chinolinen
DE1445719A1 (de) * 1961-03-21 1969-01-09 Bayer Ag Verfahren zur Herstellung von 4-Chlor- oder 4-Brom-pyrazolo[3,4-]chinolinen
DE1186867B (de) * 1961-05-03 1965-02-11 Bayer Ag Verfahren zur Herstellung von heterocyclischen Verbindungen
DE1222885B (de) * 1962-05-25 1966-08-18 Bayer Ag Optische Aufhellungsmittel
US3600393A (en) * 1969-03-03 1971-08-17 Aldrich Chem Co Inc Dialkylamino alkylamino pyrazolo (3,4b) quinolines
JPS4826797A (sk) * 1971-08-07 1973-04-09
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines

Also Published As

Publication number Publication date
ZA746138B (en) 1975-10-29
SE419760B (sv) 1981-08-24
SE7412275L (sk) 1975-04-02
FI57414B (fi) 1980-04-30
DK516274A (sk) 1975-06-30
JPS5059396A (sk) 1975-05-22
NO143223B (no) 1980-09-22
FI281574A (sk) 1975-04-02
NO743528L (sk) 1975-04-28
FI57414C (fi) 1980-08-11
CA1032538A (en) 1978-06-06
GB1488692A (en) 1977-10-12
CY1087A (en) 1980-12-27
USB402657I5 (sk) 1976-04-06
NO143223C (no) 1981-01-02
DE2446821A1 (de) 1975-04-10
CH619712A5 (sk) 1980-10-15
MY8100219A (en) 1981-12-31
US4013665A (en) 1977-03-22
FR2245369A1 (sk) 1975-04-25
BE820400A (fr) 1975-03-26
KE3086A (en) 1980-11-07
FR2245369B1 (sk) 1978-07-28
HK59380A (en) 1980-10-31
AU7379874A (en) 1976-04-01
ES430554A1 (es) 1977-07-01
CH622793A5 (sk) 1981-04-30
NL7412959A (nl) 1975-04-03
JPS582948B2 (ja) 1983-01-19

Similar Documents

Publication Publication Date Title
AT390257B (de) Verfahren zur herstellung neuer imidazo(4,5-b)chinolin-derivate
DE69426422T2 (de) Pyridazino-chinolin verbindungen
CH621552A5 (sk)
DE2419970A1 (de) Tertiaere cyclische amine und verfahren zu ihrer herstellung
DE1695556B2 (de) 3Alkyl-l,2,3,4,4a,9-hexahydropyrazino [1,2-f] morphanthridinderivate
DE2815724C2 (sk)
CH639662A5 (de) Imidazoazine und imidazodiazine.
CH494234A (de) Verfahren zur Herstellung von Pyridoindolderivaten
DE2333603A1 (de) Neue derivate von dipyrazolopyridinen und ihre salze
EP0133530A2 (de) 1,6-Naphthyridinon-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2635516B2 (de) Neue Derivate des Thiazole [3,4-b] isochinoline, ihre Herstellung und die sie enthaltenden Zusammensetzungen
CH617701A5 (sk)
DE3814057A1 (de) 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2519059A1 (de) Neue aminoderivate von 6-phenylpyrazolo(3.4-b)pyridinen
DE2916577A1 (de) Neue derivate des isochinolins, ihre herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen
DE1206437B (de) Verfahren zur Herstellung von neuen 4-Aza-thioxanthenderivaten
DE2949395A1 (de) Verwendung von substituierten chinazolinen zur behandlung von hochdruck und bradykardie sowie als kardiotone wirkstoffe
DE2106038B2 (de) 2-Imidazolin-2-ylamino-benzo [b] thiophene und diese enthaltende pharmazeutische Präparate
EP0189898A1 (de) 1,6-Naphthyridinon-Derivate und Verfahren zu deren Herstellung
DE1445438C (sk)
EP0113911B1 (de) Pyrido-triazolochinazoline, ihre Herstellung und Verwendung
DE3204074C2 (sk)
DE1670143C3 (sk)
EP0054672A1 (de) Lactamverbindungen, diese enthaltende Arzneimittel und Verfahren zur Herstellung dieser Verbindungen und Arzneimittel
CH634069A5 (en) Process for preparing novel 7-substituted 7H-pyrrolo[3,2-f]quinazoline-1,3-diamines

Legal Events

Date Code Title Description
PL Patent ceased